Skip to main content
Market intelligence
PBYIHealthcare

Puma Biotechnology Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jul 6, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 6, 2026Alan H AuerbachPresident and CEOSale44,058$8.26$364,051
Jul 6, 2026Douglas M HuntSee RemarksSale8,460$8.26$69,905
Jul 6, 2026Maximo F NouguesChief Financial OfficerSale9,386$8.26$77,557